|
1
|
Thompson MP and Kurzrock R: Epstein-Barr
virus and cancer. Clin Cancer Res. 10:803–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma SD, Tsai MH, Romero-Masters JC, Ranheim
EA, Huebner SM, Bristol JA, Delecluse HJ and Kenney SC: Latent
membrane protein 1 (LMP1) and LMP2A collaborate to promote
Epstein-Barr virus-induced B cell lymphomas in a cord
blood-humanized mouse model but are not essential. J Virol.
91:e01928–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pandya J and Walling DM: Oncogenic
activity of Epstein-Barr virus latent membrane protein 1 (LMP-1) is
down-regulated by lytic LMP-1. J Virol. 80:8038–8046. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lavorgna A and Harhaj EW: EBV LMP1: New
and shared pathways to NF-kB activation. Proc Natl Acad Sci USA.
109:2188–2189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ikeda O, Miyasaka Y, Yoshida R, Mizushima
A, Oritani K, Sekine Y, Kuroda M, Yasui T, Fujimuro M, Muromoto R,
et al: BS69 cooperates with TRAF3 in the regulation of Epstein-Barr
virus-derived LMP1/CTAR1-induced NF-kappaB activation. FEBS Lett.
584:865–872. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shkoda A, Town JA, Griese J, Romio M,
Sarioglu H, Knöfel T, Giehler F and Kieser A: The germinal center
kinase TNIK is required for canonical NF-κB and JNK signaling in
B-cells by the EBV oncoprotein LMP1 and the CD40 receptor. PLoS
Biol. 10:e10013762012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gires O, Kohlhuber F, Kilger E, Baumann M,
Kieser A, Kaiser C, Zeidler R, Scheffer B, Ueffing M and
Hammerschmidt W: Latent membrane protein 1 of Epstein-Barr virus
interacts with JAK3 and activates STAT proteins. EMBO J.
18:3064–3073. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farrell PJ: Epstein-Barr virus and cancer.
Annu Rev Pathol. 14:29–53. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kilger E, Kieser A, Baumann M and
Hammerschmidt W: Epstein-Barr virus-mediated B-cell proliferation
is dependent upon latent membrane protein 1, which simulates an
activated CD40 receptor. EMBO J. 17:1700–1709. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shair KH, Schnegg CI and Raab-Traub N: EBV
latent membrane protein 1 effects on plakoglobin, cell growth, and
migration. Cancer Res. 68:6997–7005. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tu C, Zeng Z, Qi P, Li X, Guo C, Xiong F,
Xiang B, Zhou M, Liao Q, Yu J, et al: Identification of genomic
alterations in nasopharyngeal carcinoma and nasopharyngeal
carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Carcinogenesis. 39:1517–1528. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsao SW, Wang X, Liu Y, Cheung YC, Feng H,
Zheng Z, Wong N, Yuen PW, Lo AK, Wong YC and Huang DP:
Establishment of two immortalized nasopharyngeal epithelial cell
lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim
Biophys Acta. 1590:150–158. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lo AK, Liu Y, Wang XH, Huang DP, Yuen PW,
Wong YC and Tsao GS: Alterations of biologic properties and gene
expression in nasopharyngeal epithelial cells by the Epstein-Barr
virus-encoded latent membrane protein 1. Lab Invest. 83:697–709.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahsan N, Kanda T, Nagashima K and Takada
K: Epstein-Barr virus transforming protein LMP1 plays a critical
role in virus production. J Virol. 79:4415–4424. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xin B, He Z, Yang X, Chan CP, Ng MH and
Cao L: TRADD domain of Epstein-Barr virus transforming protein LMP1
is essential for inducing immortalization and suppressing
senescence of primary rodent fibroblasts. J Virol. 75:3010–3015.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gallardo-Vera F, Diaz D, Tapia-Rodriguez
M, Fortoul van der Goes T, Masso F, Rendon-Huerta E and Montaño LF:
Vanadium pentoxide prevents NK-92MI cell proliferation and IFNg
secretion through sustained JAK3 phosphorylation. J Immunotoxicol.
13:27–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smirnova KV, Diduk SV, Senyuta NB and
Gurtsevitch VE: Molecular biological properties of the Epstein-Barr
virus LMP1 gene: Structure, function and polymorphism. Vopr
Virusol. 60:5–13. 2015.(In Russian). PubMed/NCBI
|
|
19
|
Uchida J, Yasui T, Takaoka-Shichijo Y,
Muraoka M, Kulwichit W, Raab-Traub N and Kikutani H: Mimicry of
CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.
Science. 286:300–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou C, Dai X, Chen Y, Shen Y, Lei S, Xiao
T, Bartfai T, Ding J and Wang MW: G protein-coupled receptor GPR160
is associated with apoptosis and cell cycle arrest of prostate
cancer cells. Oncotarget. 7:12823–12839. 2016.PubMed/NCBI
|
|
21
|
He Y and Smith R: Nuclear functions of
heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci.
66:1239–1256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Y, Brown MA, Rothnagel JA, Saunders NA
and Smith R: Roles of heterogeneous nuclear ribonucleoproteins A
and B in cell proliferation. J Cell Sci. 118:3173–3183. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu HC, Ma J, Zhuang Z, Qiu F, Cheng HL and
Shi JX: Exploring the regulatory role of isocitrate dehydrogenase
mutant protein on glioma stem cell proliferation. Eur Rev Med
Pharmacol Sci. 20:3378–3384. 2016.PubMed/NCBI
|
|
24
|
Bentz GL, Whitehurst CB and Pagano JS:
Epstein-Barr virus latent membrane protein 1 (LMP1)
C-terminal-activating region 3 contributes to LMP1-mediated
cellular migration via its interaction with Ubc9. J Virol.
85:10144–10153. 2011. View Article : Google Scholar : PubMed/NCBI
|
